Bse Healthcare - Today's Top Losers Stocks in Indian Stock Markets | Top Losers Intraday Stocks List

	Company Name	Sector	CMP	Price Change	Market Cap (Cr)	Current PE	Industry P/E	TTM EPS (Rs.)	DeciZen
1	Dr. Reddys Labs.	Healthcare	1,270	-5.85%	1,05,987 Mid Cap	32.92	49.85	38.57	1 Q V PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Shree Ganesh Remed.	Healthcare	677	-2.03%	869 Small Cap	48.92	49.85	13.84	2 Q V PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Nephrocare Health	Healthcare	632	-1.51%	6,338 Small Cap	0.00	93.05	-0.80	3 Q V+ PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Gland Pharma	Healthcare	2,469	-0.95%	40,729 Small Cap	31.34	49.85	78.78	1 Q V PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Tarsons Products	Chemicals & Fertilizers	288	-0.83%	1,533 Small Cap	67.68	37.77	4.26	2 Q V+ PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Sanofi India	Healthcare	3,355	-0.70%	7,728 Small Cap	24.94	49.85	134.52	1 Q V PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Sanofi Cons. Health	Healthcare	4,508	-0.66%	10,383 Small Cap	40.26	49.85	111.98	3 Q V+ PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Natco Pharma	Healthcare	961	-0.65%	17,221 Small Cap	13.44	49.85	71.55	1 Q V PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Strides Pharma Scien	Healthcare	1,074	-0.53%	9,898 Small Cap	53.90	49.85	19.92	3 Q V+ PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Astrazeneca Pharma	Healthcare	8,111	-0.48%	20,278 Small Cap	108.14	49.85	75.01	1 Q V PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Emcure Pharma	Healthcare	1,808	-0.35%	34,290 Small Cap	46.78	49.85	38.64	1 Q V PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	3B Blackbio Dx	Healthcare	1,171	-0.28%	1,005 Small Cap	20.38	113.49	57.46	2 Q V PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Jubilant Pharmova	Healthcare	968	-0.27%	15,423 Small Cap	775.03	49.85	1.25	2 Q V+ PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Suraksha Diagnostic	Healthcare	263	-0.02%	1,372 Small Cap	40.27	93.05	6.54	1 Q V PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Bse Healthcare - Top Losers Today

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.